Login
Toggle navigation
Videos
Categories
Trending
Telling founders no Board meeting etiquette|Michael Luciani,Managing Partner,Climate Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Managing Partner at Climate Capital.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Early stage fund that helps accelerate growth|Elizabeth Weil,Founder and Managing Director,Scribble Ventures
00:10:00
Koen Dejonckheere Discusses Gimv's Role in Modern Healthcare | Koen Dejonckheere, CEO, GIMV Corporate.
00:10:00
CEO Insights: Chart Industries Prepares for LNG and Hydrogen Futures | Jillian C. Evanko - CEO of Chart Industries, Inc.
00:10:00
From Janitor's Son to Leader: Chad's Journey at JP Morgan Chase
00:10:00
Golden Caribou Resources CEO Discusses Promising Drill Results and Financing
00:10:00
Introducing HPS Sentinel Series and Titan® N: Enhanced Transformers for Enhanced Protection | Adrian Thomas - CEO of Hammond Power Solutions
00:10:00
Decoding the Carbon Impact of Renewable Energy Credits
00:10:00
ETF 360: Ed Rosenberg Discusses Latest ETF Trends with American Century Investments
00:10:00
Our Approach to Real Estate Investing: Insights from Brad Morrissey and Brian Butt of Johnson Investment Counsel
00:10:00
Embracing the 'Never Normal': Insights from Peter Hinssen | Schroders Investor Download Podcast
00:10:00
Kingfisher Metals: Advancing High-Grade Exploration in British Columbia
00:10:00
Dan Smith Discusses Global Base Metals Market Trends and the Impact of China's Economic Dynamics at the London Metal Exchange